Skip to main content

Table 2 Microbiology and treatment parameters

From: Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

  Inappropriate (n = 80) Appropriate (n = 10) P value
Microbiology*    
   C. albicans 53 (66.3%) 5 (50.0%) 0.319
   C. glabrata 13 (16.3%) 2 (20.0%) 0.671
   C. parapsillosis 8 (10.0%) 2 (20.0%) 0.307
   C. tropicalis 4 (5.0%) 1 (10.0%) 0.453
   C. kruzei 2 (2.5%) 0 1.000
   C. lucitaniae 1 (1.3%) 0 1.000
Fluconazole susceptible 63 (78.8%) 8 (80.0%) 1.000
Antifungal treatment¶    
   Fluconazole 42 (52.5%) 6 (60.0%) 1.000
   Caspofungin 35 (43.8%) 4 (40.0%)  
   Amphotericin B 2 (2.5%) 0  
   Voriconazole 1 (1.3%) 0  
Antifungal delayed 24+ hours 76 (95.0%) 0 <0.001
Inappropriate dose 21 (26.3%) 0 0.109
CVC removed 58 (82.9%) 6 (75.0%) 0.629
  1. All p values are derived via Fisher's exact test
  2. *Total number adds up to over 100% due to overlap in pathogens detected
  3. ¶Does not add up to 100% due to rounding